Evaluation of a Biomarker Test for the Early Molecular Profiling of Lung Cancer Utilizing Cytological Samples (ATLAS DHF 011-003P)

General Information Age Group Adults Status Recruiting Protocol Number U20-12-2343 Background Information The purpose of this research is to collect patient specimens. These experimental specimens will be used to develop a biomarker test determining the specific molecular profile of lung nodules under investigation for possible lung cancer. The molecular profile of a nodule that is found to be cancerous may enable earlier and more specific treatment for patients diagnosed with lung cancer. If you choose to participate in this study, additional small tissue specimens matching those already being taken during your routine diagnostic procedure will be collected. Blood samples will also be collected during a routine blood draw around the time of your procedure. The specimens will be compared to the final diagnosis of your lung nodule that was identified by your doctor. This research includes genome sequencing (determining the order of DNA building blocks (nucleotides) in your genetic code). Offered At Inova Schar Cancer Institute 8081 Innovation Park Drive Fairfax, VA 22031A department of Inova Fairfax Hospital Inova Fairfax Hospital 3300 Gallows Road Falls Church, VA 22042 Eligibility Information Adults over the age of 21 Scheduled to undergo a procedure such as bronchoscopy, thoracentesis or CT-guided biopsy Able to complete a participant questionnaire Additional eligibility in protocol Ineligibility Information Participants who require a legally authorized representative to provide consent Current participation in an investigational device or drug study (except for other diagnostic tests which are acceptable) Additional ineligibility in protocol. Contact Information Contact Name Mahwish Bari Contact Phone 571-472-1796 Contact Email Send Email